Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells

Endocrinology

Volumn 150, Issue 1, 2009, Pages 14-23

  Adams, Brian D ^a   Claffey, Kevin P ^b   White, Bruce A ^a,c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ARGONAUTE 2 PROTEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BETA ACTIN; BETA CATENIN; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL AGGREGATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; FEMALE; GENETIC TRANSFECTION; GROWTH INHIBITION; HALF LIFE TIME; HUMAN; HUMAN CELL; INHIBITION KINETICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; VECTOR CONTROL; WOUND HEALING;

BREAST NEOPLASMS; CELL AGGREGATION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CYCLOHEXIMIDE; DISEASE PROGRESSION; EUKARYOTIC INITIATION FACTOR-2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; WOUND HEALING;

EID: 58149457065     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0984     Document Type: Article

References (59)

1. Meister G, Tuschl T 2004 Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349
2. Filipowicz W, Jaskiewicz L, Kolb FA, Pillai RS 2005 Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 15:331-341
3. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R 2004 The microprocessor complex mediates the genesis of micro RNAs. Nature 432:235-240
4. Wu L, Fan J, Belasco JG 2006 Micro RNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103:4034-4039
5. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz W 2005 Inhibition of translational initiation by Let-7 Micro RNA in human cells. Science 309:1573-1576
6. Pillai RS, Bhattacharyya SN, Filipowicz W 2007 Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17:118-126
7. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T 2004 Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15:185-197
8. Peters L, Meister G 2007 Argonaute proteins: mediators of RNA silencing. Mol Cell 26:611-623
9. Parker JS, Barford D 2006 Argonaute: a scaffold for the function of short regulatory RNAs. Trends Biochem Sci 31:622-630
10. Carmell MA, Xuan Z, Zhang MQ, Harmon GJ 2002 The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 16:2733-2742
11. Song JJ, Smith SK, Hannon GJ, Joshua-Tor L 2004 Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305:1434-1437
12. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ 2004 Argonaute2 is the catalytic engine of mammalian RNAi. Science 305:1437-1441
13. Yuan YR, Pei Y, Ma JB, Kuryavyi V, Zhadina M, Meister G, Chen HY, Dauter Z, Tuschl T, Patel DJ 2005 Crystal structure of A. aeolicus Argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol Cell 19:405-419
14. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T 2002 Singlestranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110: 563-574
15. Deshpande G, Calhoun G, Schedl P 2005 Drosophila argonaute-2 is required early in embryogenesis for the assembly of centric/centromeric heterochromatin, nuclear division, nuclear migration, and germ-cell formation. Genes Dev 19:1680-1685
16. Tsukioka H, Takahashi M, Mon H, Okano K, Mita K, Shimada T, Lee JM, Kawaguchi Y, Koga K, Kusakabe T 2006 Role of the silkworm argonaute2 homolog gene in double-strand break repair of extrachromosomal DNA. Nucleic Acids Res 34:1092-1101
17. Robb GB, Brown KM, Khurana J, Rana TM 2005 Specific and potent RNAi in the nucleus of human cells. Nat Struct Mol Biol 12:133-137
18. Maniataki E, Mourelatos Z 2005 Human mitochondrialt RNAMet is exported to the cytoplasm and associates with the Argonaute 2 protein. RNA 11:849-852
19. Kiriakidou M, Tan GS, Lamprinaki S, De Planell-Saguer M, Nelson PT, Mourelatos Z 2007 An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 129:1141-1151
20. Rudel S, Flatley A, Weinmann L, Kremmer E, Meister G 2008 A multifunctional human Argonaute2-specific monoclonal antibody. RNA 14:1244-1253
21. Morita S, Horii T, Kimura M, Goto Y, Ochiya T, Hatada I 2007 One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation. Genomics 89:687-696
22. Alisch RS, Jin P, Epstein M, Caspary T, Warren ST 2007 Argonaute2 is essential for mammalian gastrulation and proper mesoderm formation. PLoS Genet 3:e227
23. O'Carroll D, Mecklenbrauker I, Das PP, Santana A, Koenig U, Enright AJ, Miska EA, Tarakhovsky A 2007 A slicer-independent role for Argonaute 2 in hematopoiesis and the micro RNA pathway. Genes Dev 21:1999-2004
24. Rehwinkel J, Natalin P, Stark A, Brennecke J, Cohen SM, Izaurralde E 2006 Genome-wide analysis of mRNAs regulated by Drosha and Argonaute proteins in Drosophila melamogaster. Mol Cell Biol 26:2965-2975
25. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressier L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM 2006 The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96
26. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavare S, Caldas C, Miska EA 2007 Micro RNA expression profiling of human breast cancer identifies new markers of tumour subtype. Genome Biol 8:R214
27. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH 2002 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536
28. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ 2006 Cancer statistics, 2006. CA Cancer J Clin 56:106-130
29. Giacinti L, Claudio PP, Lopez M, Giordano A 2006 Epigenetic information and estrogen receptor α expression in breast cancer. Oncologist 11:1-8
30. Lapidus RG, Nass SJ, Davidson NE 1998 The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3:85-94
31. Adams BD, Furneaux H, White B 2007 The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21:1132-1147
32. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ 2001 Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-1150
33. Fitzpatrick SL, LaChance MP, Schultz GS 1984 Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 44:3442-3447
34. Salomon DS, Brandt R, Ciardiello F, Normanno N 1995 Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183-232
35. Woodburn JR 1999 The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82:241-250
36. McKay MM, Morrison DK 2007 Integrating signals from RTKs to ERK/MAPK. Oncogene 26:3113-3121
37. Riedemann J, Takiguchi M, Sohail M, Macaulay VM 2007 The EGF receptor interacts with the type 1 IGF receptor and regulates its stability. Biochem Biophys Res Commim 355:707-714
38. Daniel AR, Qiu M, Faivre EJ, Ostrander JH, Skildum A, Lange CA 2007 Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:188-201
39. Akca H, Tani M, Hishida T, Matsumoto S, Yokota J 2006 Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells. Lung Cancer 54:25-33
40. Wang SC, Nakajima Y, Yu YL, Xia W, Chen CT, Yang CC, McIntush EW, Li LY, Hawke DH, Kobayashi R, Hung MC 2006 Tyrosine phosphorylation controls PCNA function through protein stability. Nat Cell Biol 8:1359-1368
41. Bao J, Gur G, Yarden Y 2003 Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors. Proc Natl Acad Sci USA 100:2438-2443
42. Esquela-Kerscher A, Slack FJ 2006 Oncomirs-micro RNAs with a role in cancer. Nat Rev Cancer 6:259-269
43. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH 2008 Programmed cell death 4 (PDCD4) is an important functional target of the micro RNA miR-21 in breast cancer cells. J Biol Chem 283:1026-1033
44. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY 2008 Micro RNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18:350-359
45. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S 2007 The oncogenic micro RNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67:11001-11011
46. Ambros V, Horvitz HR 1984 Heterochronic mutants of the nematode Caenorhabditis elegans. Science 226:409-416
47. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE 2005 Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122:553-563
48. Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S 2004 Genome-wide identification of highaffinity estrogen response elements in human and mouse. Mol Endocrinol 18:1411-1427
49. Yarden Y, Sliwkowski MX 2001 Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137
50. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D 2006 Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors. Cancer Res 66:3903-3911
51. DaSilva J, Xu L, Kim HJ, Miller WT, Bar-Sagi D 2006 Regulation of sprouty stability by Mnk1-dependent phosphorylation. Mol Cell Biol 26:1898-1907
52. Lenferink AE, Busse D, Flanagan WM, Yakes FM, Arteaga CL 2001 ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Cancer Res 61:6583-6591
53. Ohta T, Fukuda M 2004 Ubiquitin and breast cancer. Oncogene 23:2079-2088
54. Chen C, Seth AK, Aplin AE 2006 Genetic and expression aberrations of E3 ubiquitin ligases in human breast cancer. Mol Cancer Res 4:695-707
55. Zeng Y, Sankala H, Zhang X, Graves PR 2008 Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies. Biochem J 413: 429-436
56. Hanahan D, Weinberg RA 2000 The hallmarks of cancer. Cell 100:57-70
57. Vernon AE, LaBonne C 2004 Tumor metastasis: a new twist on epithelialmesenchymal transitions. Curr Biol 14:R719-R721
58. Yang J, Mani S A, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA 2004 Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927-939
59. Cohen SM, Brennecke J, Stark A 2006 Denoising feedback loops by thresholding - a new role for micro RNAs. Genes Dev 20:2769-2772